Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation

Carcinogenesis

Volumn 36, Issue 7, 2015, Pages 719-729

  Hatano, Yuichiro ^a   Semi, Katsunori ^b   Hashimoto, Kyoichi ^b   Lee, Myeong Sup ^c   Hirata, Akihiro ^d   Tomita, Hiroyuki ^a   Kuno, Toshiya ^a   Takamatsu, Manabu ^a   Aoki, Koji ^e   Taketo, Makoto M ^f   Kim, Young Joon ^g   Hara, Akira ^a   Yamada, Yasuhiro ^b  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c University of Ulsan College of Medicine   (South Korea)

^d GIFU UNIVERSITY   (Japan)

^e University of Fukui   (Japan)

^f KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR CDX1; APC PROTEIN; CDX1 PROTEIN, HUMAN; CDX1 PROTEIN, MOUSE; CDX2 PROTEIN, MOUSE; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; HOMEODOMAIN PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; GENOME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; ANIMAL; C57BL MOUSE; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY; PROMOTER REGION; TISSUE MICROARRAY; TUMOR CELL LINE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MICE, INBRED C57BL; MICE, MUTANT STRAINS; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84941633771     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv060     Document Type: Article

References (48)

1. Baylin, S.B. et al. (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer, 11, 726-734.
2. Baba, S. et al. (2009) Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus. Cancer Sci., 100, 1186-1191.
3. Yamada, Y. et al. (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. USA, 102, 13580-13585.
4. Tomita, H. et al. (2010) Suppressive effect of global DNA hypomethylation on gastric carcinogenesis. Carcinogenesis, 31, 1627-1633.
5. Oghamian, S. et al. (2011) Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice. Carcinogenesis, 32, 829-835.
6. Chen, R.Z. et al. (1998) DNA hypomethylation leads to elevated mutation rates. Nature, 395, 89-93.
7. Eden, A. et al. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455.
8. Gaudet, F. et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science, 300, 489-492.
9. Yamada, Y. et al. (2002) Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice. Cancer Res., 62, 6367-6370.
10. Taylor, S.M. et al. (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell, 17, 771-779.
11. Garcia-Manero, G. et al. (2011) Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J. Clin. Oncol., 29, 516-523.
12. Juergens, R.A. et al. (2011) Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov., 1, 598-607.
13. Tsai, H.C. et al. (2012) Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell, 21, 430-446.
14. Beck, F. (2004) The role of Cdx genes in the mammalian gut. Gut, 53, 1394-1396.
15. Guo, R.J. et al. (2004) The role of Cdx proteins in intestinal development and cancer. Cancer Biol. Ther., 3, 593-601.
16. Hryniuk, A. et al. (2012) Cdx function is required for maintenance of intestinal identity in the adult. Dev. Biol., 363, 426-437.
17. Silberg, D.G. et al. (1997) CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology, 113, 478-486.
18. Vider, B.Z. et al. (1997) Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem. Biophys. Res. Commun., 232, 742-748.
19. Mallo, G.V. et al. (1997) Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int. J. Cancer, 74, 35-44.
20. Chan, C.W. et al. (2009) Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proc. Natl. Acad. Sci. USA, 106, 1936-1941.
21. Yeung, T.M. et al. (2011) Hypoxia and lineage specification of cell linederived colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA, 108, 4382-4387.
22. Arango, D. et al. (2012) Villin expression is frequently lost in poorly differentiated colon cancer. Am. J. Pathol., 180, 1509-1521.
23. Ashley, N. et al. (2013) Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors. Cancer Res., 73, 5798-5809.
24. Suh, E.R. et al. (2002) DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. J. Biol. Chem., 277, 35795-35800.
25. Xu, X.L. et al. (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J. Gastroenterol., 10, 3441-3454.
26. Wong, N.A. et al. (2004) Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc. Natl. Acad. Sci. USA, 101, 574-579.
27. Lei, H. et al. (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development, 122, 3195-3205.
28. Hatano, Y. et al. (2011) Genetic ablation of a candidate tumor suppressor gene, Rest, does not promote mouse colon carcinogenesis. Cancer Sci., 102, 1659-1664.
29. Kakizaki, F. et al. (2010) CDX transcription factors positively regulate expression of solute carrier family 5, member 8 in the colonic epithelium. Gastroenterology, 138, 627-635.
30. Muñoz, J. et al. (2012) The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J., 31, 3079-3091.
31. Hirata, A. et al. (2013) Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium. Development, 140, 66-75.
32. Lin, H. et al. (2006) Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol. Cell. Biol., 26, 2976-2983.
33. Fre, S. et al. (2005) Notch signals control the fate of immature progenitor cells in the intestine. Nature, 435, 964-968.
34. van Es, J.H., et al. (2005) Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature, 435, 959-63.
35. Barker, N. et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature, 449, 1003-1007.
36. Ohm, J.E. et al. (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet., 39, 237-242.
37. Schlesinger, Y. et al. (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet., 39, 232-236.
38. Widschwendter, M. et al. (2007) Epigenetic stem cell signature in cancer. Nat. Genet., 39, 157-158.
39. Viré, E. et al. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature, 439, 871-874.
40. Katsurano, M. et al. (2012) Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene, 31, 342-351.
41. Abu-Remaileh, M. et al. (2015) Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer. Cancer Res, 75, 2120-2130.
42. Gius, D. et al. (2004) Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell, 6, 361-371.
43. Sadanandam, A. et al. (2013) A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med., 19, 619-625.
44. Hinoi, T. et al. (2001) Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am. J. Pathol., 159, 2239-2248.
45. Lugli, A. et al. (2008) Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Mod. Pathol., 21, 1403-1412.
46. Baba, Y. et al. (2009) Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin. Cancer Res., 15, 4665-4673.
47. Dawson, H. et al. (2014) Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Int. J. Cancer, 134, 2342-2351.
48. Hryniuk, A. et al. (2014) Cdx1 and Cdx2 function as tumor suppressors. J. Biol. Chem., 289, 33343-33354.